In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Acasti Pharma, Inc.. Trade Record

NASDAQ:ACST Acasti Pharma, Inc. stock gains 5.64% Exit Feb 21, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart ACST Feb 17, 2017, priceSeries
About Acasti Pharma, Inc.

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of various cardiometabolic disorders primarily abnormalities in blood lipids. The company offers Onemia, a medical food product for the dietary management of omega-3 phospholipids deficiency, and related abnormal lipid profiles and cardiometabolic disorders. It also develops CaPre, a prescription drug candidate for the prevention and treatment of cardiometabolic disorders, such as hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Trade Information
Trade Type
LONG
ReliabilityScore™
90.20
Entry Date
Feb 17, 2017
Entry Price
1.33
Sell Date
Feb 21, 2017
Sell Price
1.41
Net Gain
5.64%
Hold Time
1 Trading Days